Widening Participation & Spreading Excellence

About this programme

In order to close the research and innovation gap between the European Member States, the Commission has designed the Spreading Excellence and Widening Participation strategy. Measures supported under this strategy will help low R&I performing EU countries to increase their participation in Horizon Europe.

There is a wide range of actions that can be used to achieve this objective from enhancing research and innovation capacity, spurring national reforms, facilitating brain circulation, launching measures for promoting excellence to creating new collaborative networks across the EU and supporting the opening of established networks to applicants from widening countries.

The 2023-2024 Work Programme will include four traditional widening instruments in addition to a number of novel elements included in the advancing Europe package agreed by the legislators in March 2019 to create impact on the above mentioned actions:

  • creating new or upgrading existing centres of excellence (Teaming);
  • significantly improving the research and innovation capacity of universities and research organisations (Twinning);
  • attracting and maintaining high quality human resources in research organisations (ERA Chair);
  • ensuring scientific networking, capacity building and career development support to researchers (COST actions);
  • strengthen regional innovation excellence in placed based innovation ecosystems (Excellence hubs);
  • transforming the higher education sector and their surrounding ecosystems (European Excellence Initiative);
  • setting up interfaces between different funding systems (Pathways to synergies);
  • improving the effectiveness of the dissemination and exploitation strategy of widening actions (Dissemination and Exploitation Support Facility);
  • involving partners from low R&I performing countries in already selected projects in Pillar 2 (Hop On Facility).
Click to read more 
Hide text 

Your NCP contact for this programme

Image of Man Hei To

Man Hei To

manhei.to@fwo.be

+32 2 550 15 55

Your PC contact for this programme

Find the contact info on the site of WEWIS

The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.

The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.

Latest news

Upcoming events

No events that are specifically related to Widening Participation & Spreading Excellence were found. Check the full calendar.

Work Programme & Calls

We offer a handy Excel file, weekly updated, containing an up-to-date overview of the Horizon Europe calls. call topics overview

Infosheets

Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.

Documents

Documents contain additional information related to this programme, and are similar to related links.

    No documents available for this domain

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.